This month’s Research Digest highlights the breadth of ME/CFS research, spanning biological mechanisms, clinical assessment, diagnostic inequities, and care for people with severe illness. The featured studies examine potential biomarkers of illness severity, the impact of autonomic dysfunction, disparities in diagnosis, and outcomes from specialised care. Together, these findings reinforce ME/CFS as a complex, multi-system condition and

The 123rd edition of the Research Digest highlights advances across theory, care, treatment and biology in long COVID and ME/CFS. A new model suggests that chronic inflammation, immune dysregulation and autonomic imbalance together underpin the complexity of Long COVID. A qualitative study reveals that incorporating lived-experience experts can enhance clinicians’ understanding of PAIS and enhance

Welcome to the 122nd edition of the Research Digest. This month’s studies continue to advance understanding of ME/CFS, highlighting biological differences between post-infectious and gradual-onset ME/CFS, uncovering new insights into how extracellular vesicles may drive post-exertional malaise (PEM), and exploring brain metabolism changes following exercise. We also feature a large international survey on patient-reported treatment outcomes

Welcome to the 121st edition of the Research Digest. In this issue, we explore new research into the neurological and genetic underpinnings of ME/CFS and long COVID, including links to neurodegeneration and neuropsychiatric conditions. We also share findings on the effectiveness of telehealth for homebound individuals, and an Australian study highlighting the profound impact of

The 120th edition of the Research Digest brings together recent research exploring ME/CFS, long COVID, fibromyalgia, and post-viral conditions. The articles included highlight advances in understanding the biological, genetic, and immunological factors underlying these illnesses, as well as potential markers for diagnosis and severity. Together, they provide a snapshot of current developments and emerging insights

This month’s Research Digest highlights new studies advancing our understanding of ME/CFS, long COVID, and related conditions. An Australian POTS study reveals that women experience more severe symptoms and longer diagnostic delays than men. A long COVID Belgian study links severe fatigue symptoms with signs of accelerated ageing and cardiac involvement, while a Harvard-led analysis

This month’s edition of the Research Digest highlights new biomedical findings on ME/CFS and long COVID, with a focus on immune dysfunction, autoimmunity, and potential biomarkers. Studies reveal shared pathways between the two conditions, including elevated autoantibodies and interferon activity. Research into B-cell receptors and BH4 metabolism adds to our understanding of immune and cardiovascular

In this month’s 117th edition of the Research Digest, we explore advancements in the understanding and diagnosis of post-viral conditions, including long COVID and ME/CFS. Highlights include a new algorithm to improve long COVID diagnosis across diverse populations, a comparison of cognitive challenges in ME/CFS and multiple sclerosis, and promising insights from tryptophan metabolism research.

Welcome to the 116th edition of the Research Digest! In this issue, we explore emerging blood-based biomarkers for ME/CFS and share findings from a study highlighting the high burden of chronic overlapping pain conditions and their impact on health and quality of life. From the long COVID field, new research links persistent spike protein in

Welcome to the 115th edition of Emerge Australia’s Research Digest. This edition explores post-acute sequelae of COVID-19 (PASC) mechanisms, with magnetic resonance imaging (MRI) and cognitive studies revealing lasting brain alterations and impairments. Comparative studies of ME/CFS with PASC highlight both shared and distinct dysfunctions. Beyond research, the lived experiences of Australians with long COVID

The 114th edition of the Research Digest covers studies on potential treatments, biomarkers, and risk factors for long COVID and ME/CFS. Highlights include intravenous immunoglobulin as a possible therapy, biomarkers distinguishing long COVID patients with ME/CFS symptoms, a large paediatric study on risk factors and recovery, and a review of microRNAs in disease mechanisms. We

Welcome to the 113th and final edition of the Research Digest for 2024. This edition highlights significant findings on the growing challenges of long COVID and its connection to ME/CFS. The featured articles delve into the global, social, and economic impacts of long COVID, explore opportunities for research and treatment, and underscore the urgent need